Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2024
Individual- and Community-Level Social Determinant Associations With Acoustic Neuroma Disparities in the United States.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fei-Zhang David J, Sethia Rishabh, Abrahamson Cyrus W, Sosnoski Olivia K, Sheyn Anthony M, D'Souza Jill N, Chelius Daniel C, Rastatter Jeffrey C
Аннотация
OBJECTIVE: This investigation aims to determine whether community-level social determinants of health (SDoH) influenced acoustic neuroma outcomes more profoundly than individual-level SDoH through the use of multivariate models and census-level socioeconomic status (SES) measures.
STUDY DESIGN: Observational, retrospective cohort study. Setting: Specially Authorized Head-Neck SEER 2020 Dataset.
PATIENTS: 23,330 adult (20+ yr) patients diagnosed with acoustic neuroma from 2010 to 2018.
MAIN OUTCOME MEASURES: Age-adjusted multivariate regressions and hazard models were performed for individual level (sex, race-ethnicity) and community-level factors (Yost Index-SES, rurality-urbanicity) to assess for differences in acoustic neuroma treatment, including delay of intervention, treatment receipt, and overall survival.
RESULTS: Lower Yost-SES/community-level SES had a markedly positive association with an increase in all-cause mortality (HR, 1.55; 95% CI, 1.41-1.71) and negative association with stereotactic radiotherapy treatment (OR, 0.93; 95% CI, 0.86-0.99; p = 0.040). Patients with poor Yost-SES had a significantly positive association with receipt of surgical resection (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001).
CONCLUSIONS: Data generated from this investigation suggest that community-level SDoH, particularly Yost-SES, have more detrimental care and prognostic disparities in acoustic neuroma treatment compared with individual-level factors.
STUDY DESIGN: Observational, retrospective cohort study. Setting: Specially Authorized Head-Neck SEER 2020 Dataset.
PATIENTS: 23,330 adult (20+ yr) patients diagnosed with acoustic neuroma from 2010 to 2018.
MAIN OUTCOME MEASURES: Age-adjusted multivariate regressions and hazard models were performed for individual level (sex, race-ethnicity) and community-level factors (Yost Index-SES, rurality-urbanicity) to assess for differences in acoustic neuroma treatment, including delay of intervention, treatment receipt, and overall survival.
RESULTS: Lower Yost-SES/community-level SES had a markedly positive association with an increase in all-cause mortality (HR, 1.55; 95% CI, 1.41-1.71) and negative association with stereotactic radiotherapy treatment (OR, 0.93; 95% CI, 0.86-0.99; p = 0.040). Patients with poor Yost-SES had a significantly positive association with receipt of surgical resection (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001).
CONCLUSIONS: Data generated from this investigation suggest that community-level SDoH, particularly Yost-SES, have more detrimental care and prognostic disparities in acoustic neuroma treatment compared with individual-level factors.